Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 04, 2026 09:00 ET | Source: Stipple Bio, Inc.

Stipple Bio Enters Multi-Target License Agreement with Lonza to Advance Precision Oncology ADC Therapies

– Multi-target agreement positions Stipple Bio to advance next-generation ADC therapies using Lonza’s clinically validated ADC platform — — Stipple Bio’s Pointillist Platform identifies...
April 06, 2026 07:00 ET | Source: Stipple Bio, Inc.

Stipple Bio Emerges From Stealth with Oversubscribed $100 Million Series A Financing to Advance STP-100 into Early Clinical Studies and Advance a Precision Oncology Pipeline that Leverages its Pointillist Platform

– Series A financing co-led by RA Capital, a16z Bio+Health and Nextech Invest, and includes participation from existing investors Emerson Collective Investments (managed by Yosemite), GV (Google...